ASSEMBLY BIOSCIENCES, INC.
ASMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001426800
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
92
- +17 vs. Q1 2026
- Total value $514.8M
Superinvestors holding ASMB
0
- None of the superinvestors held ASMB at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by ASMB insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Jun 17, 2026 | Bjorkquist Jeanette MPFO and PAO | SSaleCommon Stock | −29 | $23.25 | −$674.25 | 14.56K | −0.2% | SEC |
| Mar 31, 2026 | Mar 30, 2026 | Bjorkquist Jeanette MPFO and PAO | SSaleCommon Stock | −328 | $26.691 | −$8.75K | 11.09K | −2.9% | SEC |
| Mar 31, 2026 | Mar 30, 2026 | White Nicole SChief Manufacturing Officer | SSaleCommon Stock | −197 | $26.6884 | −$5.26K | 37.48K | −0.5% | SEC |
| Oct 3, 2025 | Aug 8, 2025 | GILEAD SCIENCES, INC.10% Owner | PPurchaseCommon Stock | +2.3M | – | – | 4.51M | +103.9% | SEC |
| Oct 3, 2025 | Aug 8, 2025 | GILEAD SCIENCES, INC.10% Owner | PPurchaseCommon Stock · Derivative | +2.3M | – | – | 1.15M | – | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in ASMB at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 4,977,089 | $136.77M | 8.30% | +471,698+10.5% | Added |
| Farallon Capital Management, L.L.C. | 1,604,590 | $44.09M | 0.26% | +377,000+30.7% | Added |
| Paradigm Biocapital Advisors LP | 1,553,748 | $42.7M | 0.80% | +888,497+133.6% | Added |
| COMMODORE CAPITAL LP | 1,415,000 | $38.88M | 2.32% | +415,000+41.5% | Added |
| RA CAPITAL MANAGEMENT, L.P. | 1,020,410 | $28.04M | 0.24% | 00.0% | Unchanged |